PubMed Health⌕ Search

Biomedical subjects

Nadia De Giovanni

Publications and source records attributed to Nadia De Giovanni.

4 recordsLinked to original sources

Hypothesis on interferences in kinetic interaction of microparticles in solution (KIMS) technology.

The present paper describes an evaluation of the interferences found with an immunochemical drug test performed during a workplace control. During the period 1993-2003 more than 200,000 urine samples from workers were examined by the Italian Air Force. Samples were screened for drugs of abuse (opiates, cocaine, cannabinoids, amphetamines, methadone) using an immunochemical technique (Roche, kinetic interaction of microparticles in solution, KIMS). A total of 520 positive samples were sent to the Forensic Toxicology Laboratory for confirmation by gas chromatography/mass spectrometry (GC/MS). Approximately 39% of these were found to be true positives. For the remaining samples, pharmacological therapy in subjects was estimated to evaluate possible interferences due to medicine intake. Our study showed a high frequency of false-positive results with this immunochemical technique, mainly for the cannabinoid and amphetamine groups. Recurrent references to some medicines during subject anamnesis were noted.

Amphetamine↗

Buprenorphine detection in biological samples.

Buprenorphine is a narcotic analgesic used in the treatment of moderate-to-severe pain. In Italy, buprenorphine is now being used as an alternative in the therapeutic treatment of heroin abusers. Even if confirmation methods are needed for identification and quantitation, a rapid and sensitive test, such as an immunoassay, is essential for screening. We evaluated the Buprenorphine One-step ELISA test (designed for serum specimens) for the qualitative determination of buprenorphine in other matrices, such as urine, saliva and hair.

Buprenorphine↗

Simultaneous detection of some drugs of abuse in saliva samples by SPME technique.

A simple method for the simultaneous determination of many drugs of abuse in saliva is referred [methadone, 2-ethyl-1,5-dimethyl-3,3-diphenylpyrrolinium perchlorate (EDDP), cocaine, cocaethylene, amphetamine, methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyethyl amphetamine (MDEA), N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB), cannabidiol (CBD), Delta(9)-tetrahydrocannabinol (THC), cannabinol (CBN)]. Head space-solid phase microextraction (HS-SPME) and direct immersion-solid phase microextraction (DI-SPME) followed by gas chromatographic/mass spectrometric analyses (GC/MS) were employed, and results obtained with both techniques are discussed. The method was validated testing reproducibility, sensitivity, linearity.

Forensic Medicine↗

Cozart Rapiscan system: our experience with saliva tests.

International literature has devoted many contributions to the evaluation of alternative biological matrices (such as saliva) as diagnostic tools in drug testing. The immunoassay Cozart Rapiscan saliva drug system, has been studied in recent years. In the present paper we report our experience with saliva collection and the quali-quantitative determination of drugs of abuse. Fifty-nine saliva samples were collected by the Cozart Rapiscan pad. Qualitative analyses were carried out by Cozart Rapiscan System and the results were confirmed by a solid-phase microextraction-GC-MS technique. Quantitative determinations were performed for methadone and its metabolite by GC-MS technique. The Cozart System provides collection and transfer procedures more easily than other systems, requiring minimal operator intervention.

Gas Chromatography-Mass Spectrometry↗